IL6 and metabolic syndrome: Studies indicate that levels of inflammatory cytokines such as TNF-α and IL-6 are elevated in the serum of MetS patients, and the persistent activation of these cytokines exacerbates myocardial injury during myocardial ischemia-reperfusion by promoting apoptosis and local inflammation (33, 34).